Top news of the week: 29.04.2021.
Healthcare
Biogen to expand access to its ALS drug, but move may come too late for some patients
“This is not going to help the dying patients. They’ll be dead before mid-July," said Robert Mauriello, whose wife has a rare form of ALS.
Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. for All Adults Aged 18 and Older Following CDC and FDA Decision
Important information for healthcare providers and the public included in updated FDA Emergency Use Authorization Fact Sheets
Ocugen Reports $100 Million Direct Share Offering at Market Premium from Institutional Investors
Ocugen Inc. shares traded up as much as 47% before closing just 3.66% higher for the day after the company announced a $100 million registered direct offering of common stock priced at a ...
STAT+ Conversations: In it for the long haul: the impact of long Covid
STAT's Gideon Gil sits down with Dr. Allison Bond of the University of California, San Francisco, to discuss Covid-19 long-haulers.
How the UK found the first effective Covid-19 treatment — and saved a million lives
The United Kingdom is not a pandemic success story. But its massive Covid-19 trials program is.
Research and censorship in an uncertain time
When scientific truths are declared by anointed experts, you don't have science you have a religion. Just because the leading experts agree that the sun revolves around the earth, that ...
Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies
Application is based on Phase 2b/3 SELECTION study data with patients with moderately to severely active ulcerative colitis Mechelen, Belgium; 23 April...
Janssen COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers 04232021
In an ongoing clinical trial, 21,895 individuals 18 years of age and older have received the Janssen COVID-19 Vaccine. Side effects that have been reported with the Janssen …